Abstract:Epidemiological studies have convincingly demonstrated that several factors of the metabolic syndrome (MetS) are associated with the risk of Renal Cell Carcinoma (RCC)These factors often occur together and it is therefore challenging to disentangle their individual causal relevance in the etiology of RCC. In order to circumvent this limitation, we have applied a Mendelian randomization (MR) approach whereby genetic markers are evaluated in relation to RCC risk as unconfounded markers of the individual MetS factors. We focused on MetS parameters from which genetic instruments could be identified from large-scale genome-wide association studies (GWAS). The following MetS factors were instrumented using multiple gene-variants: general and central obesity (body mass index (BMI) and waist-to-hip ratio), elevated blood pressure (systolic and diastolic blood pressure), dyslipidemia (high and low density cholesterol, total cholesterol, and triglycerides), hyperglycemia (fasting glucose and glucose levels at 2 hours after glucose intolerance tests), and hyperinsulinemia (fasting insulin). Genetic proxies for these parameters were identified from GIANT, ICBP, GLGC and MAGIC Consortia. Summary statistics on RCC risk for instrumental SNPs of each MetS factor, including OR estimates and standard errors, were available from GWAS coordinated by the International Agency for Research on Cancer, the US National Cancer Institute, the Institute for Cancer Research UK, and the MD Anderson Cancer Center US. Together these studies comprised a total of 12,104 RCC cases and 24,999 controls from European origin that were genotyped using different genotyping platforms. Imputation was conducted on each dataset and only SNPs with an imputation quality higher than 0.6 were considered for the analyses. The causal effect of each MetS parameter on RCC risk was subsequently estimated using the MR likelihood-based approach, assuming a linear relationship between the risk factor and the outcome and a bivariate normal distribution for the genetic association estimates. The MR risk analysis using genetic instruments of the individual MetS factors indicated that elevated BMI (P: 1×10-08) and fasting insulin (P: 7×10-04)increased the risk of RCC, whereas elevated post-load glucose levels were associated with a lower risk (P: 2×10-3). The odds ratio per standard deviation increase were estimated at 1.58 (95% CI: 1.35-1.86) for BMI, 1.77 (95%CI: 1.27-2.46) for fasting insulin, and 0.62 (95%CI: 0.46-0.83) for post-load glucose. No associations were seen for genetic instruments of blood pressure or lipids. These results provide a clear support for a causal role of obesity in RCC etiology, and suggest that factors related to hyperglycemia and/or hyperinsulinemia may be involved in the causal pathway. This study may guide future efforts aiming to clarify the biological mechanisms whereby the metabolic syndrome influences RCC pathogenesis. Citation Format: Robert Carreras-Torres, Mattias Johansson, Ghislaine Scelo, Philip Haycock, Mark Purdue, Xifeng Wu, Richard Houlston, Stephen Chanock, Paul Brennan. Identifying causal risk factors of metabolic syndrome for renal cell carcinoma. A Mendelian randomization approach. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 4349.

High Circulating Insulin-Like Growth Factor-1 Reduces the Risk of Renal Cell Carcinoma: a Mendelian Randomization Study

Causal Relationship Between Kidney Function and Cancer Risk: A Mendelian Randomization Study

Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses

Genetic variation in IGF1 predicts renal cell carcinoma susceptibility and prognosis in Chinese population

Circulating insulin-like growth factor-1 and risk of lung diseases: A Mendelian randomization analysis

Insulin-related Traits and Prostate Cancer: a Mendelian Randomization Study

Association Between Circulating Levels Of Igf-1 And Igfbp-3 And Lung Cancer Risk: A Meta-Analysis

Mendelian randomization analysis reveals causal relationships between circulating cell traits and renal disorders

Insulin-like Growth Factors and Prostate Cancer

A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

Joint Effect of Insulin-Like Growth Factors and Mutagen Sensitivity in Lung Cancer Risk.

Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

Lower Circulating Adiponectin is Associated with Higher Risk of Renal Cell Carcinoma: A Meta-Analysis

The Influence of Obesity-Related Factors in the Etiology of Renal Cell Carcinoma—a Mendelian Randomization Study

Associations Between Circulating Insulin-Like Growth Factor 1 and Mortality in Women With Invasive Breast Cancer.

Plasma Levels Of Insulin-Like Growth Factor-I And Lung Cancer Risk: A Case-Control Analysis

Abstract 4349: Identifying Causal Risk Factors of Metabolic Syndrome for Renal Cell Carcinoma. A Mendelian Randomization Approach

Genetically Predicted Circulating Levels of Cytokines and the Risk of Cancer

Genes in the insulin and insulin-like growth factor pathway and odds of metachronous colorectal neoplasia

Mendelian randomization analysis demonstrates the causal effects of IGF family members in diabetes

Plasma Levels of Insulin-Like Growth Factor-1 and Binding Protein-3, and Their Association with Bladder Cancer Risk